AIGEN Sciences
AIGEN Sciences induce desired cellular-level activity with minimal off-target effects and toxicity and offer high-potency drug generation with minimal off-target effects, enabling pharmaceutical researchers to get effective drugs rapidly and achieve higher success rates in clinical trials while reducing costs and improving efficiency.
$8.60M
Latest Funding
Series A
Latest Funding Stage
2024-10-21
Funding Date
7
Employees
South Korea
Location
Seoul, Seoul-t'ukpyolsi
City & State
Key Contacts
Open Positions
View Careers PageSimilar Startups
Workhelix
Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Unique
Unique is an AI-driven platform transforming financial operations through agentic AI solutions. We help financial institutions streamline middle- and back-office processes, ensuring efficiency, compliance, and security at scale.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.